Katina Venetos, MD
Dermatology · Lake Forest, ILNPI 1336256437
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.2% of the total across 567 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,715 and has fallen 56.1% since, to $1,629 in 2025.
Across 567 payments — averaging $28.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- LEO Pharma Inc.$1K
- Amgen$1K
- E.r. Squibb & Sons, L.L.C.$924
- Lilly USA, LLC$866
- Medimetriks Pharmaceuticals, Inc.$852
- plus $8K from 32 others
Across 8 payments — averaging $10,565 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Taro Pharmaceuticals USA, Inc.$51K
- Sun Pharmaceutical Industries Inc.$34K
What the payments were for
- Consulting fees$7004%
- Speaking & faculty fees$660%
- Food & beverage$15,23495%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Skyrizi$827
- Clindacin ETZ$700
- Sumadan Wash$700
- Neo-Synalar$700
- Sotyktu$620
- Otezla$475
- Tovet (emollient formulation)$350
- GRAFIX PL$279
- DUPIXENT$239
- TALTZ$228
- XEOMIN$224
- OPZELURA$223
- SOFDRA$147
- Grafix$140
- NEMLUVIO$128
- VTAMA$125
- YCANTH$122
- BOTOX COSMETIC$121
- BOTOX$120
- Bimzelx$120
How this compares
$16,001 in reported general payments places this provider in the 85th percentile of 606 dermatology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 105 | $4,012 |
| Ketoconazole | 162 | $3,186 |
| Clobetasol Propionate | 54 | $2,682 |
| Fluocinolone Acetonide | 54 | $2,107 |
| Mometasone Furoate | 123 | $1,966 |
| Metronidazole | 39 | $1,642 |
| Triamcinolone Acetonide | 168 | $1,599 |
| Hydrocortisone | 108 | $754 |
| Doxycycline Hyclate | 17 | $590 |
| Fluocinonide | 13 | $411 |
| ValacyclovirValacyclovir Hcl | 36 | $292 |
| SsdSilver Sulfadiazine | 13 | $113 |
| Mupirocin | 12 | $103 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Lake Forest
- Ahmad AminNaperville$4.1M
- Raj ChovatiyaChicago$3.6M
- George LewittNorthbrook$3M
- Peter LioChicago$2.4M
- Elizabeth KiracofeChicago$1.6M
- Lana SchmidtEffingham$1.3M
- Melissa AbramsVernon Hills$600K
- Carolyn JacobChicago$566K
- Walter LiszewskiChicago$414K
- Emily RubensteinLincolnshire$359K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.